Joint & Bone Health

Ingredients supplier Bioiberica has revamped the brand identity for its healthcare ingredients portfolio as part of the company’s long-term growth strategy.

An update on the new research and developments in antioxidant ingredients.

The two companies will collaborate to leverage their combined capabilities to set a roadmap for the future of vitamin K2.

The Herbal Pharmacist’s take on leading ingredients to fight inflammation

Sports supplements are increasingly taking a holistic approach to maintaining peak performance.

Although the joint health consumer skews older, some of the creative new products coming to market might also capture the attention of younger demographics by fitting more conveniently into their daily routine.

ParActin Andrographis paniculata from HP Ingredients, was granted a product license (#80109555) from Health Canada to support joint health symptoms.

Bone health is a top priority for some consumers, but not all. The supplements industry would like to see that change.

A recently published study found that a dispersible palmitoylethanolamide (PEA), called Levagen+ may help alleviate joint discomfort.

Bioiberica has partnered with Apsen to develop a mobility product for the Brazilian market. The product, Motilex HA, combines two of Bioiberica’s leading joint health ingredients: b-2Cool native type 2 collagen, and Mobilee hyaluronic acid.

Lonza has launched an organic and Non-GMO Project Verified version of its UC-II collagen ingredient.

A recent study compared the effects of a bioavailable turmeric extract (BCM-95 from Arjuna Naturals; Dallas, TX) at a dose of 500 mg twice daily to 650 mg of paracetamol (also known as acetaminophen) three times daily for six weeks.

Enterprising companies and scientific institutions are finding new uses for familiar marine ingredients and in some cases reinventing the raw materials as we know them.

Omya announced that results of a recent in vitro study that compared the bioavailability of its newly developed source of calcium, Omyaforte 100, with other frequently used calcium salts.

A recently-published study found that supplementation with a specific collagen peptides from Gelita significantly reduced exercise-induced knee pain.

Health Canada has recently reviewed and approved a new pain claim for Stratum Nutrition’s NEM brand eggshell membrane. The claim reads: “NEM helps provide relief from joint pain due to moderate intensity aerobic exercise as quickly as the first day.”

Kerry entered into a strategic licensing partnership with Pharma Foods International Co. Ltd. (PFI) in which Kerry has access to the joint health technology developed by PFI.

Using quantitative proteomics, researchers in a recent study evaluated the holistic efficacy of JointAlive from Chenland Nutritionals.

Vitamin D saw sales and usage grow in 2020, including possibly due to emerging research linking vitamin D supplementation with COVID-19 outcomes. Hear experts discuss why science will keep the spotlight on vitamin D in 2021.

Predictions from Nutritional Outlook's esteemed Editorial Advisory Board.

Gelita recently added Immupept to its line of bioactive collagen peptides. The new ingredient features optimized peptide profiles for stimulation of collagen-rich connective tissues involved with immune response.

Stratum Nutrition and Ayalla announced ANVISA, the National Health Surveillance Agency of the Brazilian Ministry of Health, granted “safety and efficacy as a bioactive substance” pre-market approval of NEM brand eggshell membrane.

In the midst of a pandemic, consumers are putting greater value on the role of nutrients in good health.

In a joint press release, AstaReal, Beneo, and Gelita are highlighting the potential of the emerging e-sports and gaming market for food and dietary supplement manufacturers.

Focusing on the digital space and more has offered companies new platforms for communication.